✦ LIBER ✦

Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status

✍ Scribed by Delia Kurzwelly; Martin Glas; Patrick Roth; Elke Weimann; Hanns Lohner; Andreas Waha; Martin Schabet; Guido Reifenberger; Michael Weller; Ulrich Herrlinger

Book ID: 106481222
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 146 KB
Volume: 97
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-009-0032-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tailored temozolomide therapy according

Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia

✍ Bruno C. Medeiros; Holbrook E. Kohrt; Jason Gotlib; Steven E. Coutre; Bingyang Z 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

Salvage treatment with temozolomide in r

Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status

✍ Keishi Makino; Hideo Nakamura; Taku-ichiro Hide; Jun-ichi Kuratsu 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 249 KB

Temozolomide and methotrexate for primar

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly

✍ Antonio M. P. Omuro; Luc Taillandier; Olivier Chinot; Charlotte Carnin; Maryline 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 183 KB

Temozolomide concomitant and adjuvant to

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma : Correlation with MGMT promoter methylation status

✍ Alba A. Brandes; Enrico Franceschi; Alicia Tosoni; Francesca Benevento; Luciano 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Benefits of interferon-β and temozolomid

Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter : A multicenter study

✍ Kazuya Motomura; Atsushi Natsume; Yugo Kishida; Hiroyuki Higashi; Yutaka Kondo; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

## Abstract ## BACKGROUND: The aim of the current study was to catalog genomic and epigenomic abnormalities in newly diagnosed glioblastoma patients and determine the correlation among clinical, genetic, and epigenetic profiles and clinical outcome. ## METHODS: This study retrospectively include

Prognostic value of immunohistochemical

Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma

✍ Hiroyuki Momota; Yoshitaka Narita; Akiko M. Maeshima; Yasuji Miyakita; Aya Shino 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 285 KB